(Meth)Amphetamines harm reduction - PLEASE SHARE THIS AROUND!
--- We here atFADQtry to provide the best possible Harm Reduction practices. ---
I will be covering most aspects of harm reduction. If there is something missing, do inform me.
The post might be very detailed, however such detail is necessary, these compounds are very complex.
If you have any subjective experiences you would like to add, with for example methamphetamine I will include it.
This post has taken me about +20 hours to write, my(our) aim is to make it as complete and useful as possible, but it is still in progress. I would to thank everyone who has contributed to this post, we hope that it will be of universal help.
During heavy use, all of these compounds will quickly make you loose the the ability to think in a sober, and non-addictive manner. Often this is not too noticeable to begin with, it gradually goes to shit.
Sometimes on drug subs you'll find these ridiculous posts, where the OP has absolutely no regard to safety. It makes us all look & feel bad, every stimmer should know what, and what not to do. If you are curious about this class of drugs and want to try them, do your own extensive research first! This post does not cover everything...
Once you start messing with amphetamines a bit too much it can lead to devastating long term effects that may or may not be permanent.
Seriously, pharmaceutical or not, the same dangers apply. They are relative in terms of damage.
It is of great value to read this post carefully but to also read the included sources, knowledge is everything and we are striving for a more educated and respected society.
INTRO - Biochemistry and general pharmacology of amphetamines
Amphetamine is a methyl homolog of the mammalian neurotransmitter phenethylamine(PEA) with the chemical formula C9H13N. All substances based on amphetamine are part of the class of compounds called Substituted amphetamines.
Substituted amphetamines include:
All derivative compounds which are formed by replacing, or substituting, one or more hydrogen atoms in the amphetamine core structure with substituents.
The compounds in this class span a variety of pharmacological subclasses, including stimulants, empathogens, and hallucinogens, among others.
Examples of substituted amphetamines are: amphetamine (Its the building block of all amps |"Speed paste", adderall...), methamphetamine(Meth,tina,speed), 3,4-Methylenedioxymethamphetamine (MDMA,molly) and 2,5-Dimethoxy-4-chloroamphetamine (DOC) .
Amphetamines tend to vary greatly in strength, duration and potency, but its pharmacology is usually similar. Most of the compounds act as seriously potent monoamine releasing agents - full agonists of trace amine-associated receptor 1 (TAAR1), which is a G protein coupled receptor.
In humans the effects of the compounds cause increased cellular communication or neurotransmission of dopamine, serotonin, norepinephrine, epinephrine, histamine, CART peptides, endogenous opioids, adrenocorticotropic hormone, corticosteroids, and glutamate, which it effects through interactions with the receptors CART, 5-HT1A, EAAT3, TAAR1, VMAT1, VMAT2, and possibly other biological targets.
--- The relatively complex pharmacology of these substances are probably the causes of the potential acute suicide idealization and generally depressive effects it gives upon cessation of (ab)use, although these compounds are not physically addictive, I believe that the endogenous opioid release is a major factor in amphetamines "withdrawal", much like nicotine's endogenous opioid releasing properties.
Both nicotine and amphetamines can create typical opioid withrdawal effects such as flu symptoms during abrupt cessation of heavy use, but for amphetamines it only appears to occur after serious abuse everyday for weeks in a row. ---
However some amphetamines such as substituted-2,5-Dimethoxyamphetamines (DOx) differ from traditional amphetamines, they are solely potent and long-lasting psychedelic drugs, and act as highly selective 5-HT2A, 5-HT2B, and 5-HT2C receptor partial agonists.
ΔJunD, a transcription factor, and G9a, a histone methyltransferaseenzyme, both directly oppose the induction of ΔFosB in the nucleus accumbens (i.e., they oppose increases in its expression) Sufficiently overexpressing ΔJunD in the nucleus accumbens with viral vectors can completely block many of the neural and behavioral alterations seen in chronic drug abuse (i.e., the alterations mediated by ΔFosB). ΔFosB also plays an important role in regulating behavioral responses tonatural rewards, such as palatable food, sex, and exercise.
Since both natural rewards and addictive drugsinduce expressionof ΔFosB (i.e., they cause the brain to produce more of it), chronic acquisition of these rewards can result in a similar pathological state of addiction.ΔFosB is the most significant factor involved in both amphetamine addiction and amphetamine-inducedsex addictions, which are compulsive sexual behaviors that result from excessive sexual activity and amphetamine use.
These sex addictions (i.e., drug-induced compulsive sexual behaviors) are associated with a dopamine dysregulation syndromewhich occurs in some patients takingdopaminergic drugs, such as amphetamine or methamphetamine.
'' Methamphetamine addiction is persistent for many individuals (seen as the most dangerous one) with 61% of individuals treated for addiction relapsing within one year. About half of those with methamphetamine addiction continue with use over a ten-year period, while the other half reduce use starting at about one to four years after initial use. '' --- Thismay not be subjectively true. ---
|
|
|
|
|
|
ROA - Route Of Administration
ROAs can produce completely different highs. The reason why people don't simply take all their drugs orally for example is because of the first pass metabolism, oral ingestion means that the substance will have to first be metabolized through the liver and eventually be released into the bloodstream to reach its pharmacological targets, many ROAs try to prevent hepatic first pass metabolism..
--- Potency of ROAs are listed from weakest to strongest ---
ORAL INGESTION - This ROA will generally always be the mildest one, it is very useful when you need to stay active and actually work without going on a 10 hour masturbation session. Oral ingestion also has the mildest comedown, milder comedowns means less depression, and less addiction(Slower release of monoamines results in less gene expression).
SUBLINGUAL - This ROA is very similar to insufflation, but there may be less of a "rush", however it can be used as an alternative to insufflation, I believe it can be as effective. Keep in mind that the tongue might eventually be damaged because of the corrosive properties these substances have.
INSUFFLATION - This ROA is already vastly more addictive and shorter in duration than oral ingestion, the monoamine release rate is a lot faster. The aim when snorting drugs is to get as much of the substance as possible through the Nasal mucosa membranes to bypass the first pass metabolism, however amphetamines have a generally poor bio-availability(BA) intranasally, but it certainly does the job better than oral. Too much insufflation and you are bound to destroy those poor little membranes... Comedowns can suck a lot when snorting. Filling your nose with chemicals is never smart, I would advise to wash out your nasal cavities when you're insufflating, a saline water solution usually clears the nose rather effectively.
RECTAL ADMINISTRATION - Also commonly called "boofing" or "plugging", it is the process of, literally, shoving drugs up your asshole. This method, just like insufflation aims to quickly enter the bloodstream. Rectal administration is seriously stronger than insufflation, there are some big veins around your rectum, it results in 2/3rds of the drug bypassing first pass metabolism. Your bowels must be emptied before administering drugs this way. Biovailability is thought to be around 95-99% rectally, I can confirm that boofing is VERY addictive, it produces almost immediate noticeable effects, including jaw trembles and awesome euphoria. This ROA will also result in less nausea.
For IV and smoking amphetamines I cannot say much as I haven't tried them. But those ROAs seem to get you highveryquickly.Injecting anything is a risk, especially street drugs. DO NOT smoke amphetamine sulphate or any Rx amphetamines, the compound will only be destroyed, from what I hear only methamphetamine can be smoked.IV ADMINISTRATION GUIDE
|
|
|
|
|
|
HARM REDUCTION : Taking precautions - Moderation is key.
---To begin with, if you plan on indulging in the use of these substances you must be aware of certain things: ---
Amphetamines are extremely addictive(psychologically), the addiction is very sneaky and creeps up on you, expect the unexpected. Dependency on these drugs arises quickly sometimes, it can go really fast, literally 0 to 100. Can impact quality of living, bringing a lot of users down on their knees, battling addiction. Many of these compounds are known to cause neurotoxicity, especially when abused repeatedly in a short period of time
If you are predisposed to or have mental illness(es) it would be wise to avoid touching these, drugs. Amphetamines can triggerStimulant psychosis(highly prominent even in normal individuals), it can have unpredictable, even catastrophic social, physiological and psychological consequences for the user
Amphetamines tend to deplete certain neurotransmitters(mainly serotonin and dopamine), and can cause long lasting brain fog, depression, and other undesirable effects.The compounds hijack the brain's reward system and can cause serious long term dopaminergic and serotonergic receptor downregulation.
Amphetamines are not to be underestimated, they are powerful CNS-stimulants. They will quickly turn your life into a living hell if you loose control too much, its up to you to set your own boundaries.This reddit post can be useful to look at from time to time. If you do not have enough self control, these compounds will put you at serious risk of ruining your life.
|
|
|
|
|
|
Sleep is for the weak?... No.
---Try to avoid staying up for dayswith these drugs, it is not good for you. Past 24-48 hours you will be stepping into psychosis territory and it isn't nice. ---
Sleep deprivation may lead to permanent epigenetical changes. The brain is one of the organs most impacted by sleep deprivation; It impacts synaptic plasticity and the maintenance of synapse strength, and cognitive abilities, including learning and memory. Details of how sleep deprivation causes these epigenetic changes are not fully understood. However, it is well known that sleep deprivation alters numerous signaling pathways, which could regulate epigenetic mechanisms. One important unanswered question is if sleep recovery following deprivation can restore the epigenome to its initial state. To answer this question, future sleep studies should obtain samples after recovery from sleep deprivation. This will allow investigation into the fluidity of epigenetic marks following sleep deprivation, and determine if the changes are sustained or returned to baseline once sleep is restored. Source : Sleep Deprivation and the Epigenome - Department of Molecular Physiology and Biophysics, Iowa Neuroscience Institute, Carver College of Medicine, University of Iowa, Iowa City, IA, United States - Published online 2018 Feb 27. PMCID: PMC5835037 PMID: 29535611
|
|
|
|
|
|
STIMULANT PSYCHOSIS
Dont smoke weed with too much amphetamines in your system, it can be a serious trigger for psychosis, but it can also damage your heart...
IN CASE OF (WIKIPEDIA)STIMULANT PSYCHOSIS (Psychosis is also HIGHLY INDICATIVE of a possible overdose, or at least damaging signs)
Antipsychotics will be your way out, but benzodiazepines can come in handy as well, sleep deprivation usually causes a faster onset of psychosis, be careful.. If you dont have any of these meds, eating moderate amounts of food is also very useful and can rapidly decrease symptoms.
WARNING! ANTIPSYCHOTICS CAN RESULT IN DEATH(Arrhythmia, tachycardia etc... I have woken up with a HR of 170-193 after neuroleptic use for sleep post-stimulant use) WHEN COMBINED WITH STIMULANTS, therefore co-administration of GABAergic drugs(Benzodiazepines, Ethanol to a certain extent, valerian, Z-drugs, GHB(ligand of GABA B) etc... GABAA receptor PAM, GABAergics) is imperative for safety.
Psychosis (can feel very similar toMuscarinic antagonisticdelerium, also known asDeliriant Drugs) may vary in magnitude, often it is progressive as the user continues to use knowing fully well that it will only get worse, it can manifest in effects such as:
- Excited delirium, Delusions, often accompanied by Mania combined with a belief that one is superior to others: Grandiose delusions (GD)
---->Schizophrenic behavior, may be accompanied by rapidly shifting bipolarity - sudden mood swings
---->Delusional parasitosis, often accompanied by Formication(the sensation that resembles that of small insects crawling on/or under the skin)
- Erratic behavior and high irritability
- Memory loss (blackouts)
- Amphetamine Withdrawal Psychosis (AWP), although rare and not formally recognized a condition, it happens to many.
- Panic attacks, severe anxiety
|
|
|
|
|
|
Is it possible to overdose? Yes it is.
Amphetamine overdoses are rare, but these drugs all have serious peripheral cardiovascular effects. Most overdoses are caused by the user's ignorance or polydrug use.
Overdosing can result in effects such as:
- Aggression and delusions of grandiosity
- Psychosis
- Anterograde amnesia, similar to benzodiazepines, along with mania and psychosis this can become a deadly cocktail.
- Strong body trembles or even seizures
- Dangerously high blood pressure and rapid heartbeat
- Extreme hyperthermia
- Coma or even death.
Overdose can occur even in first-time users, depending on the amount of drug used in one sitting. However, the overall risk of overdose may be greater in those who have developed an amphetamine addiction, and begin compulsively using the drug—placing themselves in harm’s way time and again.
Furthermore, during overdose or long term abuse of amphetamines, rhabdomyolysis can become a serious concern.
Rhabdomyolysis causes skeletal muscles to break down rapidly. Symptoms may include muscle pains, weakness, vomiting, and confusion. There may be tea-colored urine or an irregular heartbeat. Some of the muscle breakdown products, such as the protein myoglobin, are harmful to the kidneys and may lead to kidney failure.
What to do in case of overdose:
Hospital is your best bet, but depending on the users state, the user may also be able to take benzodiazepines and manage the overdose.
Benzodiazepines can save a life.
If the user is unresponsive, he will need to be rushed to an ICU immediately.
|
|
|
|
|
|
So what should you do before, during and after your use to stay healthy and decrease potential toxicity? Let me tell you.
Acute loss of appetite is common during the influence of these drugs, it can lead to starvation and dehydration. Make sure to be well hydrated and make sure to have eaten a decent meal beforehand. DO NOT go +15 hours without any nutrition, you will thank me later.
Eating when you're high on these compounds will be almost impossible, you will have to force feed yourself, sometimes leaning on numerous supplementscanhelp with preventing serious damage.
Stimulant (ab)use tends to drain your body of resources very quickly, more than we think.
This list is based on research, severalrecovery tipsand my own experience(some details are yet to be added):
It MUST BE NOTED that supplements will not compensate for malnutrition!!
1. Multivitamins(before,during and after use)
Multivitamins are extremely useful and make sure you get all vitamins you need, they are also really affordable and are generally safe. The main ones that are important: all Vitamin B, Vitamin C and Vitamin D complexes. Eating food with vitamins can increase its absorption.
--- > In the context of vitamins, using vitamin C can increase the body's clearance rate of any ingested amphetamine, meaning it can for example get you to sleep faster, it is also an antioxidant. (Amphetamines clearance rate is pH-dependent)
--------------> Vitamin D(mainly D3) can help improve long term dopaminergic neurotransmission, even reduce damage caused by monoamine auto-oxidation and depletion.
"Vitamin D Significantly Upregulates the D2 Dopamine Receptor, Increases Dopamine Synthesis, and Potentiates the Effects of Amphetamine in rats"
Anecdotally I find Vitamin D to be very effective. It is a supplementation that ought to be recommended in the case of frequent stimulant use, enough sunlight will achieve the same result, but it can be hard during wintertime.
Taking minerals can be very useful during the influence of amphetamines, magnesium will help with jaw clenching, it has many other important roles in the body. Calcium can help immensely as well. I find that mineral deficiency can make a comedown much worse, make sure to take enough of these. Multivitamin brands usually include minerals as well.
3. Omega 3(when necessary)
DHA and EPA are fatty acids that can mainly be found in marine ecosystems (fish, algae etc...). They cannot be produced in our bodies, having a deficiency of them is very common. They are of vast importance for normal brain functioning.
4. Tryptophan(before and after use / when necessary)
An α-amino acid that is used in the biosynthesis of proteins, it is a precursor to the neurotransmitter serotonin, the hormone melatonin and vitamin B3.
Most amphetamines affect serotonin by acting as releasing agents, the long term serotonergic deficiencies that can occur are not intriguing, h even small amounts of tryptophan before and after drug use can be beneficial to replenishing the body's supply, it can prevent post-stimulant induced depression, improve cognitive function, and improve sleep.
5. Tyrosine(after use)
Supplementing with exogenous precursors to dopamine has not showed major beneficial effects for me, they may even increase tolerance to the amphetamine by further downregulating dopaminergic receptors. However when quitting amphetamines they can be useful to function fairly normally.
(MORE TO COME)
|
|
|
|
|
|
Oxidative Stress and prevention of neurotoxicity
Amphetamines toxicity involves the occurrence of at least three acute events: an increase in extracellular and intracellular DA, an increase in extracellular GLU, and hyperthermia. The major classical molecular mechanisms by which these events subsequently produce long-term effects include oxidative stress, excitotoxicity, and mitochondrial dysfunction.
So neurotoxicity occurs when at least these 3 points occur:
Increase in extra- and intracellular dopamine(DA)
Excitotoxicity by too much glutamate(GLU). Glutamate is an excitatory neurotransmitter in the body. Amphetamines can cause neurons to overexcite, hence the neuronal damage.
Hyperthermia - Overheating
For reduction of possible toxicity:
-N-acetylcysteine (NAC)
While many antioxidants have been researched to treat a large number of diseases by reducing the negative effect of oxidative stress, acetylcysteine is one of the few that has yielded promising results, and is currently already approved for the treatment of paracetamol overdose. NAC has been proven to reduce amphetamines neurotoxicity.
Melatonin is a hormone that regulates sleep-wake cycles. This hormone is primarily produced by the pineal gland. As a medication, it is used for the short-term treatment of trouble sleeping such as from jet lag or shift work. Melatonin also acts as a high-capacity free radical scavenger within mitochondria which also promotes the expression of antioxidant enzymes such as superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase via signal transduction through melatonin receptors
- NMDA receptor antagonists
NMDA antagonism showed a great reduction in excitotoxicity in many studies. That means that dissociatives(ketamine, dxm) can help, or any other substance with that pharmacologic property(for example Magnesium).
Emoxypine inhibits free radical[which?] oxidation of biomembrane lipids, reacts to peroxide radicals of lipids primary and hydroxyl radical of peptides
Increases the content of polar fraction of lipids (phosphatidyl serine and phosphatidyl inositol) and reduces the cholesterol/phospholipids ratio which proves its lipid-regulatory properties; shifts structure transition into the low temperature zones, that is provokes the reduction of membrane viscosity and the increase of its fluidity, increases lipid-protein ratio.
Modulates the receptor complexes of the brain membranes, i.e. benzodiazepine, GABA, acetylcholine receptors by increasing their binding ability.
Stabilizes biomembranes, i.e. membrane structures of blood cells - erythrocytes and thrombocytes during their haemolysis or mechanical injury accompanied by the formation of free radicals.
Changes the monoamine level and increases the dopamine content in the brain.[3][7]
(MORE TO COME)
|
|
|
|
|
|
Can these compounds be "purified"? Yes, to some extent.
(* in this case it is an equal mixture of Dextro- and Levo- enantiomers, also called a racemate)
- Possible dangers of "EU speed paste"
European speed is normally a referral to racemic* amphetamine sulphate.
In the European speed culture, it is commonly used for going to raves. Sometimes, speed paste can be horribly cut with inactive but also active substances such as: caffeine, ephedrine, methamphetamine etc... This puts you at risk of excessive use caused by unintentional polydrug use, further increasing the risk of overdose.
The paste is also usually cut with solvents to make it "wet" to increase weight. It is necessary to dry your amphetamine sulphate in order to avoid these dangerous solvents.
For additional harm reduction, acetone washing amphetamine once its been dried is also a must. Amphetamine is insoluble in acetone, while most cuts, not all are very soluble(e.g caffeine). Amphetamine synthesized in Europe is made clandestinely, so washing it can also help remove toxic byproducts that were created during its synthesis
- Other amphetamines may also be acetone washed to obtain a cleaner product.
SPECIAL HARM REDUCTION GUIDE TO MDxx COMPOUNDS(MDMA, MDA...)
MDxx compounds are amphetamines that have a methylenedioxide group attached to them.
This makes their serotonin releasing properties much more potent and consequently less potent dopamine releasers.
It is believed that serotonin release is a major factor in amphetamines neurotoxicity, hence why amphetamine(near zero 5HT release) is considered less toxic than methamphetamine(minor 5HT release).
These compounds will have similar techniques in harm reduction, however the neurotoxicity tends to be much worse than the parental compounds that is amphetamine and methamphetamine.
These specifically potent 5HT releasers also carry along the risk of dying from too much serotonin(Serotonin syndrome or serotonin toxicity).
It is a painful condition that can manifest in effects such as:
RCs and other drugs being sold as Ecstasy - a real danger.
During recent years, ecstasy (E,XTC) has been increasing in popularity.
The term ecstasy used to be a term that referred to a pill thats been pressed, containing only one active ingredient - MDMA.
Ecstasy has now become the preferred raving drug. But the reprisal of Ecstasy has now become dangerous because ecstasy isnt purely MDMA anymore, pills may contain dangerous RCs instead of MDMA, or even both combined.
When you find real ecstasy though, they usually contain +300mg MDMA sometimes, which is a ridiculously high dosage of MDMA, granted MDMA overdoses are rare, but for a first timer 300mg is much too much. 300mg can lead to long lasting depression and brain damage.
Rule number one of ecstasy use: Start with half, a quarter even and work you way up.
European(not only in Europe) ecstasy is either a mixture of MDMA + Amphetamine sulphate, creating a seriously addictive and euphoric high, or they are dirty pills that can have shocking contents such as :
NOTE: I am not particularly interested in the science behind it, but rather in actual subjective experiences from people that have taken it! I edited the post and added the pharmacology at the very bottom for those interested.
Hi everybody,
I have a question that I hope some of you could help me out with. I was wondering if anyone here has experience with both Adderall and Vyvanse (not taken together but at different times) and would want to share their personal experience with both drugs. To be clear: I'm not asking about the pharmacology or science about both drugs, I am just curious to hear about peoples personal subjective experience with them. A big reason for me asking this question is that currently in my country Vyvanse is not a registered medication, while in the USA it is (succesfully) prescribed to a lot of people with ADHD/ADD.
Anyone that (preferably) has been on both drugs (either prescribed or recreational) that would want to take a minute to describer their differences for you personally would be greatly appreciated! If you are kind enough to leave a reply,
please include whether or not the drug was prescribed to you (and if you don't mind: for which indication).
PM: If you have had any other medications used in treatment for ADD/ADHD prescribed to you (either now or in the past) and want to share a bit about their subjective effects in comparison to one another please feel free to do so!
Big thanks in advance!
-CultriX-
Addendum:
Pharmacology
Vyvanse (or lisdexamphetamine) is a 100% pure dextro-isomer of amphetamine (as opposed to Adderall which is 75% Dextroamphetamine and 25% Levoamphetamine), but it's coupled to an amino acid Lysine which makes it so that it's inactive until the Lysine is split from the Dextroamphetamine in the body. Because this happens gradually after ingestion peak plasms levels should not be as high as with pure Dextroamphetamine or Adderall. This also is thought to make it less prone to abuse/addiction/recreational.
Although I'm familiair with the reasoning behind it and how it works, I am very curious to hear from some people that tried both to hear if they actually experience it that way / differently.
ROA's
It is a common misconception that snorting Vyvanse won't have any effects because it has to be metabolised in the gastrointestinal tract. The L-Lysine actually gets split from the Dexamfetamine in red blood cells, which means that oral (PO: per os) or intransal (IN) administration doesn't really differ that much (unlike other drugs!)
Ketamine is a medication mainly used for starting and maintaining anesthesia.It induces a trance-like state while providing pain relief, sedation, and memory loss. Other uses include for chronic pain, sedation in intensive care, and depression. Ketamine is also used as a recreational drug for its hallucinogenic effects. It is a dissociative substance of the arylcyclohexylamine class. Like other dissociatives, it acts by blocking NMDA receptors in the brain.
Pharmacodynamics
Ketamine acts as a selective antagonist of the NMDA receptor, an ionotropic glutamate receptor. It binds specifically to the dizocilpine (MK-801) site of the NMDA receptor, near the channel pore, and is an uncompetitive antagonist. Ketamine may also interact with and inhibit the NMDAR via another allosteric site on the receptor. Ketamine causes interactions with the D2high receptor, nicotinic acetylcholine receptors (by its metabolites)
Metabolites of ketamine including dehydronorketamine, hydroxynorketamine, and norketamine have been found to act as negative allosteric modulators of the α7 nicotinic acetylcholine receptor in the KXa7R1 cell line.
Mechanism of Action
Ketamine acts as a non-competitive antagonist of the NMDA receptor, an ionotropic glutamate receptor. NMDA receptors allow for electrical signals to pass between neurons in the brain and spinal column; for the signals to pass, the receptor must be open. Dissociatives close the NMDA receptors by blocking them. This disconnection of neurons leads to loss of feeling, difficulty moving, and eventually the notorious state known as the “K-hole”.
Medical Use
Anesthesia
Since it suppresses breathing much less than most other available anesthetics, ketamine is used in medicine as an anesthetic; however, due to the hallucinations it may cause, it is not typically used as a primary anesthetic, although it is the anesthetic of choice when reliable ventilation equipment is not available.
Pain management
Ketamine is an analgesic that is most effective when used alongside a low-dose opioid; because, while it does have analgesic effects by itself, the doses required for adequate pain relief when it is used as the sole analgesic agent are considerably higher and far more likely to produce disorienting side effects. A review article in 2013 concluded, "despite limitations in the breadth and depth of data available, there is evidence that ketamine may be a viable option for treatment-refractory cancer pain"
Depression
A single low, sub-anesthetic dose of ketamine given via intravenous infusion may produce antidepressant effects within four hours in people with depression. These antidepressant effects may persist for up to several weeks following a single infusion. This is in contrast to conventional antidepressants like selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), which generally require at least several weeks for their benefits to occur and become maximal. Moreover, based on the available preliminary evidence, the magnitude of the antidepressant effects of ketamine appears to be more than double that of conventional antidepressants. On the basis of these findings, a 2017 review described ketamine as the single most important advance in the treatment of depression in over 50 years. It has sparked interest in NMDA receptor antagonists for depression, and has shifted the direction of antidepressant research and development.
Recreational Use
Low Dose
mild inebriation, dreamy thinking, stumbling, clumsy, or "robotic" movement, delayed or reduced sensations, vertigo, increased sociability, and an interesting sense of seeing the world differently. Nausea and vomiting can result even from lower doses.
High Dose
Initially, a sort of fragmentation of reality may occur. Some users report that their environment seems to begin spinning, but not in a bad "alcohol spins" sort of way. Chaos may then ensue. At some point, at higher doses, many users find themselves completely removed from their surroundings and their bodies. Descriptions of the experience vary substantially, but many include talk of alternate planes of existence, a sense of movement through a space or landscape, a oneness with everything, past and future revelations, and strange fabrics or textures of all sorts. Many users have difficulty communicating during the peak of the effects, and they may not be able to see or hear others in the room. Revelations can be extremely heavy or frightening, but usually the fear does not dominate re-entry and it is therefore difficult to remember it as "scary". Some users describe the feeling of coming back across the "reality" line in a visual way, attempting to put an object in focus or define it. It is at this point that they may try to get in touch with their co-trippers. This is the "wow" period. The wise user does not try to move for a while at this point, as the experience continues mildly for an hour or so after this, with an increasingly conventional focus.
Toxicity/Safety
Neurological
The first large-scale, longitudinal study of ketamine users found current frequent (averaging 20 days/month) ketamine users had increased depression and impaired memory by several measures, including verbal, short-term memory, and visual memory. Current infrequent (averaging 3.25 days/month) ketamine users and former ketamine users were not found to differ from controls in memory, attention, and psychological well-being tests. This suggests the infrequent use of ketamine does not cause cognitive deficits, and that any deficits that might occur may be reversible when ketamine use is discontinued. However, abstinent, frequent, and infrequent users all scored higher than controls on a test of delusional symptoms.
Urinary Tract Effects
According to a 2010 systematic review, 110 documented reports of irritative urinary tract symptoms from ketamine dependence exist. Urinary tract symptoms have been collectively referred to as "ketamine-induced ulcerative cystitis" or "ketamine-induced vesicopathy" and they include urge incontinence, decreased bladder compliance, decreased bladder volume and painful haematuria (blood in urine).
The time of onset of lower urinary tract symptoms varies depending, in part, on the severity and chronicity of ketamine use; however, it is unclear whether the severity and chronicity of ketamine use corresponds linearly to the presentation of these symptoms. All reported cases where the user consumed greater than 5 grams per day reported symptoms of the lower urinary tract.
Overdose
Fatal ketamine overdoses are particularly rare, but not unheard of. However, the exact toxic dosage is unknown.
Green, SM; Roback, MG; Kennedy, RM; Krauss, B (2011. "Clinical Practice Guideline for Emergency Department Ketamine Dissociative Sedation: 2011 Update". Annals of Emergency Medicine. 57 (5: 449–61))
Zgaia, AO; Irimie, A; Sandesc, D; Vlad, C; Lisencu, C; Rogobete, A; Achimas-Cadariu, P (2015. "The role of ketamine in the treatment of chronic cancer pain". Clujul Medical. 88 (4: 457–61.))
Moaddel R, Abdrakhmanova G, Kozak J, Jozwiak K, Toll L, Jimenez L, Rosenberg A, Tran T, Xiao Y, Zarate CA, Wainer IW (2013. "Sub-anesthetic concentrations of (R,S-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors". European Journal of Pharmacology. 698 (1–3): 228–34.))
Tyler, MW; Yourish, HB; Ionescu, DF; Haggarty, SJ (2017. "Classics in Chemical Neuroscience: Ketamine". ACS Chemical Neuroscience. 8 (6: 1122–1134))
Tyler, MW; Yourish, HB; Ionescu, DF; Haggarty, SJ (2017. "Classics in Chemical Neuroscience: Ketamine". ACS Chemical Neuroscience. 8 (6: 1122–1134))
Heshmati, F; Zeinali, MB; Noroozinia, H; Abbacivash, R; et al. (December 2003. "Use of ketamine in severe status asthmaticus in intensive care unit". Iranian Journal of Allergy, Asthma, and Immunology. 2 (4: 175–80))
Elia, N; Tramèr, MR (January 2005. "Ketamine and postoperative pain: A quantitative systematic review of randomised trials". Pain. 113 (1: 61–70.))
Bredlau, AL; Thakur, R; Korones, DN; Dworkin, RH (October 2013. "Ketamine for pain in adults and children with cancer: A systematic review and synthesis of the literature". Pain Medicine. 14 (10: 1505–17.))
Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sánchez E, Gutiérrez-Rojas L, Meana JJ (May 2018. "Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review". CNS Drugs. 32 (5: 411–420.))
Singh I, Morgan C, Curran V, Nutt D, Schlag A, McShane R (May 2017. "Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight". Lancet Psychiatry. 4 (5: 419–426.))
(Index / Contents of this post can be found below)
Serotonin = 5HT
Serotonin Transporter = SERT / 5HTT
Hi all!
I wanted to share with you some important information on Serotonin Syndrome / Serotonin Toxicity. Further down this post you will find multiple pictures (see bullet points below) and a few (Free)Reference-Articles on the topic, along with a Case Report that was published which displays how diagnosis of Serotonin Syndrome can be tricky (end of post).
I hope you'll enjoy this post, lets dive headfirst into serotonin shall we?
Contents:
Serotonin (5HT), the Serotonin Transporter (SERT / 5HTT) and the synthesis of 5HT from Tryptophan. Also includes an image displaying the physiological life-cycle of serotonin in the synapses.
Symptoms often seen in Serotonin Syndrome
The Hunter-Criteria to aid in diagnosing Serotonin Syndrome
Classification on the severity of Serotonin Syndrome in a patient (and medical management)
Pharmacology: Drugs that increase the likelihood of Serotonin Syndrome (pharmacokinetics / pharmacodynamics)
Drug-Combinations known to increase risk of developing Serotonin Syndrome
Differential diagnosis for Serotonin Syndrome (syndromes that mimic it / show similar symptoms)
(Free) Articles for further reading for those interested in the topic
1) Serotonin (5HT), the Serotonin Transporter (SERT / 5HTT) and the synthesis of 5HT from Tryptophan
1.1) The Serotonin Molecular Structure:
1.2) The Serotonin Transporter (SERT / 5HTT)
1.3) The Synthesis of Serotonin from Tryptophan
1.4) the physiological life-cycle of serotonin in the synapses
2) Symptoms often seen in Serotonin Syndrome
NOTE: Before reading, please take note of the fact that Serotonin Syndrome might show a completely different presentation between individuals. Also, there are some other conditions (I'll get into those further down this post) that mimic the symptoms of Serotonin Syndrome. It is, therefore, no surprise that the condition is often misdiagnosed or with a delay before the right diagnosis is made. I included a case-report publication that I found very interesting, and which also displays very clearly how Serotonin Syndrome can be misleading at the bottom of this post.
3) The Hunter-Criteria for diagnosing Serotonin Syndrome
4) Classification of Severity of Serotonin Syndrome (and medical management)
5) Pharmacology: Drugs that increase the likelihood of Serotonin Syndrome
6) Drug-Combinations known to increase risk of developing Serotonin Syndrome
7) Differential diagnosis for Serotonin Syndrome (syndromes that mimic it / show similar symptoms)
8) (Free) Articles for further reading for those interested in the topic
3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP) which has been sold online as a designer drug.
Pharmacodynamics
3-MeO-PCP acts as an NMDA receptor antagonist. A specific subtype of glutamate receptor, NMDA (N-Methyl-D-Aspartate), modulates the transmission of electrical signals between neurons in the brain and spinal cord; for the signals to pass, the receptor must be open.
Dissociatives inhibit the normal functioning NMDA receptors by binding to and blocking them. This disruption of neural network activity leads to loss of normal cognitive and affective processing, psychomotor functioning, and anesthesia.
Mechanism of Action
3-MeO-PCP has a Ki of 20 nM for the dizocilpine (MK-801) site of the NMDA receptor, 216 nM for the serotonin transporter (SERT), and 42 nM for the sigma σ1 receptor.
It does not bind to the norepinephrine or dopamine transporter nor to the sigma σ2 receptor (Ki >10,000 nM).Based on its structural similarity to 3-hydroxy-PCP (3-HO-PCP), which uniquely among arylcyclohexylamines has high affinity for the μ-opioid receptor in addition to the NMDA receptor, it was initially expected that 3-MeO-PCP would have opioid activity. However, radioligand binding assays with human proteins have shown that, contrary to common belief, the drug also does not interact with the μ-, δ-, or κ-opioid receptors at concentrations of up to 10,000 nM. As such, the notion that 3-MeO-PCP has opioid activity has been described as a myth
Interesting Note: 3-MeO-PCP binds to the NMDA receptor with higher affinity than PCP and has the highest affinity of the three isomeric anisyl-substitutions of PCP, followed by 2-MeO-PCP and 4-MeO-PCP.
Recreational Use
3-MeO-PCP is commonly described as being more stimulating and less immobilizing than other dissociatives such as ketamine or MXE. At lower doses, it can induce sensory enhancements such as color enhancement, acuity enhancement, tactile enhancement, auditory enhancement and bodily control enhancement. However, at medium to high doses, it presents sensory suppressions such as tactile suppression, motor control loss, auditory suppression and acuity suppression. Based on a large amount of experience reports, it appears to be considerably more likely to induce mania, delusions, and psychosis than other dissociatives (possibly due to its unusually high potency, compulsivity and erratic dose response).
Oral Insufflated Smoked
Threshold
2 - 4 mg
Threshold
1 mg
Threshold
2 - 5 mg
Light
4 - 8 mg
Light
2 - 5 mg
Light
5 - 10 mg
Common
8 - 15 mg
Common
5 - 10 mg
Common
10 - 20 mg
Strong
15 - 25 mg
Strong
10 - 15 mg
Strong
20 - 25 mg
Heavy
25 mg +
Heavy
15 mg +
Heavy
25 mg +
Duration
4 - 8 hours
Duration
3 - 5 hours
Duration
45 - 120 minutes
Toxicity/Safety
Neuronal Effects
It has been reported that several uncompetitive NMDA receptor ion channel blocking agents causetransient reversible vacuolationin neurons in the posterior cingulate cortex of rats. Similar effects have also been observed with competitive glutamate antagonists such as CPP, CGS 19755 and CGP 37849. This transient morphological change has been noted to be coincident anatomically with brain regions showing hypermetabolismafter administration of uncompetitive NMDA receptor ion channel blockers and competitive glutamate antagonists.These results therefore indicate that the functional consequences of NMDA receptor blockade with competitive glutamate and uncompetitive channel antagonists are ultimately the same.These changes do not appear to be a prelude to irreversible damage except after relatively high doses of the receptor ion channel antagonists but they have given rise to concern over the safety in use of NMDA antagonists as neuroprotective agents.
Urinary Tract Effects
In terms of its long-term health effects when used repeatedly and excessively for extended periods of time, 3-MeO-PCP may produce almost identical bladder and urinary tract problems to those found within ketamine, but to a lesser extent. This is possibly because 3-MeO-PCP is far more potent than ketamine so significantly less of drug needs to be consumed. Symptoms of ketamine-induced cystitis can become extremely serious and can be described as Urinary frequency - Urinary frequency is the need to empty the bladder every few minutes. Urinary urgency - This can be described as a sudden, compelling need to urinate. Urinary pressure - This is experienced as a constant sensation of fullness in the bladder that is unrelieved by urination. Pelvic and bladder pain - Pain can develop suddenly and severely, particularly as the bladder fills with urine. Hematuria - Hematuria is visible blood in the urine. Incontinence - This is the leakage of urine.
Psychosis
3-MeO-PCP has been reported to cause psychosis, delusions, and mania at a significantly higher rate than other dissociatives such as ketamine, diphenidine, or MXE. There area large number of experience reports online which describe states of "psychotic delirium, amnesia, mania, and other serious consequences" after abusing 3-MeO-PCP.
Overdose
Fatal intoxication so far does not seem likely, the few reports of fatal intoxications appear to stem from poly drug use.however, as stated in the Toxicity/Safety section excessive doses can lead to Psychotic Manic states where an individual can lose control of their actions. In order to responsibly use this drug one must measure their dose with an accurate scale. In case of an overdose benzodiazepines would be used in a clincal setting.
Sources
Morris H, Wallach J (2014. "From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs". Drug Test Anal. 6 (7–8): 614–32.)
Hargreaves, R J, et al. “Neuroprotective NMDA Antagonists: the Controversy over Their Potential for Adverse Effects on Cortical Neuronal Morphology.” Acta Neurochirurgica. Supplementum, U.S. National Library of Medicine, 1994,www.ncbi.nlm.nih.gov/pubmed/7976530.
Cocaine is a tropane alkaloid found in the leaves of the coca plant, Erythroxylum coca. It is most commonly consumed as the hydrochloride salt which is typically produced in clandestine laboratories. Cocaine decomposes when heated strongly so the freebase and hydrogen carbonate salts of cocaine, which have much lower boiling points compared to the hydrochloride salt, are typically used when the substance is to be vaporized and are known as cocaine base and crack respectively.
Pharmacodynamics
Cocaine binds tightly at the dopamine transporter forming a complex that blocks the transporter's function. The increased concentration of dopamine in the synapse activates post-synaptic dopamine receptors,which makes the drug rewarding and promotes the compulsive use of cocaine.
Cocaine affects certain serotonin (5-HT) receptors; in particular, it has been shown to antagonize the 5-HT3 receptor. The overabundance of 5-HT3 receptors in cocaine conditioned rats display this trait, however the exact effect of 5-HT3 in this process is unclear. The 5-HT2 receptor (particularly the subtypes 5-HT2AR, 5-HT2BR and 5-HT2CR) are involved in the locomotor-activating effects of cocaine.
Mechanism of Action
The most extensively studied effect of cocaine on the central nervous system is the blockade of the dopamine transporter. This substance acts as a reuptake inhibitor and prevents dopamine from being recycled, causing excessive amounts to build up in the synapse, or junction between neurons. The result is an enhanced and prolonged post-synaptic effect of dopaminergic signaling. To a lesser extent, cocaine also exhibits functionally similar effects of reuptake inhibition upon the neurotransmitters of serotonin and noradrenaline.
Medical Use
Topical cocaine can be used as a local numbing agent to help with painful procedures in the mouth or nose.
Cocaine is now predominantly used for nasal and lacrimal duct surgery. The major disadvantages of this use are cocaine's potential for cardiovascular toxicity, glaucoma, and pupil dilation. Medicinal use of cocaine has decreased as other synthetic local anesthetics such as benzocaine, proparacaine, lidocaine, and tetracaine are now used more often.
Recreational Use
Cocaine is a powerful nervous system stimulant. Its effects can last from 15 or 30 minutes to an hour. The duration of cocaine's effects depends on the amount taken and the route of administration. Cocaine can be in the form of fine white powder, bitter to the taste. When inhaled or injected, it causes a numbing effect. Crack cocaine is a smokeable form of cocaine made into small "rocks" by processing cocaine with sodium bicarbonate (baking soda) and water. Crack cocaine is referred to as "crack" because of the crackling sounds it makes when heated.
Cocaine use leads to increases in alertness, feelings of well-being and euphoria, increased energy and motor activity, and increased feelings of competence and sexuality.
Toxicity/Safety
Occasional use of cocaine rarely causes permanent or severe trouble to the body and mind. In terms of neurotoxicity (as defined by the damage or death of cells in the brain in response to over-excitation or reactive oxidation caused by drugs), cocaine does not appear to exhibit these effects unlike certain other substances such as methamphetamine. Its extended use or abuse does, however, cause short-term down regulation of neurotransmitters.
The most potentially harmful physical effects of cocaine appear to be not neurological but cardiovascular. Long-term cocaine use may result in cocaine-related cardiomyopathy.
Overdose
Overdoses cause hyperthermia and a marked elevation of blood pressure, arrhythmias, and death.
With excessive dosage, tremors, convulsions and increased body temperature are observed. Severe cardiac adverse events, particularly sudden cardiac death, become a serious risk at high doses due to cocaine's blocking effect on cardiac sodium channels.
Interesting Note: while normal acute coronary syndrome (ACS) often gets treated with a Beta-blocking medication, this is contra-indicated when someone on cocaine develops an ACS since it will cause the heart to be able to beat less fast (beta-blocking) but won't oppose the vasoconstriction (unopposed alpha-effect). Hence: the heart can pump less blood to itself basically worsening the condition.
Hummel, M; Unterwald, EM (April 2002. "D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action". Journal of Cellular Physiology. 191 (1): 17–27)
Filip M, Bubar MJ, Cunningham KA (September 2004. "Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses". The Journal of Pharmacology and Experimental Therapeutics.)
Carta M, Allan AM, Partridge LD, Valenzuela CF (January 2003. "Cocaine inhibits 5-HT3 receptor function in neurons from transgenic mice overexpressing the receptor". European Journal of Pharmacology. 459 (2–3): 167–9)
Dwyer C, Sowerby L, Rotenberg BW (August 2016. "Is cocaine a safe topical agent for use during endoscopic sinus surgery?". The Laryngoscope (Review). 126 (8): 1721–3)
World Health Organization (2004. Neuroscience of psychoactive substance use and dependence. p. 89.)
World Health Organization (2007. International medical guide for ships. p. 242.)
Sordo L, Indave BI, Barrio G, Degenhardt L, de la Fuente L, Bravo MJ (September 2014. "Cocaine use and risk of stroke: a systematic review". Drug and Alcohol Dependence (Systematic Review). 142: 1–13.)
O'Leary ME, Hancox JC (May 2010. "Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias". British Journal of Clinical Pharmacology. 69 (5): 427–42.)
Hi all, in this post im going to try to explain to you the basics of the substance known as Kratom. This drug has gained a lot of attention lately because it's liked by people who are looking for a stimulating and euphoric effect, but it's loved by people suffering from opioid-withdrawals and by those who use it for zoning out and/or reducing the comedown of a stimulant high. Below in this post are links that display the source for the information I typed out here.
Lay-terms read:
Kratom (or Mitragyna Speciosa) is a tropical tree of the coffee family. It's effects are produced by various psychoactive alkaloids that the leaves of the plant contain. Kratom is unique in the sense that it causes both stimulating and sedating effects. This seems contradicting at first glance; how can a drug both be stimulating and sedating? Generally it's said that lower doses cause more of a stimulant effect, while higher doses cause more of an opioid-like effect. This is due to a pretty complex pharmacological mechanism which I explain in the more advanced section further down in this post. One of the main reasons why Kratom has become so popular in (alternative) medicine and the drugs community, is that some people claim that it's a great help when withdrawing from opioid-dependency or when taken as landing-gear from stimulant use.
Furthermore it's good to know that there are different strains of Kratom availabe that all have their own characteristics to them. The strains are named after the color of the veins of the leaf (red, green or white). Below are the effects that can be expected (yet it's always different for everybody!) of the different strains:
White Vein: more energetic and stimulating effects in low to moderate doses compared to the other strains
Red Vein: more sedating and relaxing, making it suided for managing insomnia and pain
Green Vein: the green strain falls in between the white- and red strains. It's not quite as stimulating as the white veins, nor as sedating as the red veins.
Traditionally, Kratom was consumed by chewing on the leaves or by making a tea by using the leaves. Today Kratom is often sold as dried and powdered leaves, sometimes being very concentrated. Keep this in mind!
More advanced read:
The leaves of M. speciosa contain over 40 compounds. The most important ones responsible for producing the drugs effects are alkaloids such as Mitragynine, Mitraphylline and 7-Hydroxymitragynine.
Pharmacology:
Kratom is an unique drug in the sense that it behaves both as an opioid receptor agonist, an opioid receptor antagonist, and finally it has affinity for norepinephrine and serotonin receptors where it behaves as an agonist. This is why the drug has both a stimulating effect in low doses, and a sedative effect in higher doses.
To be exact:
Mitragynine and 7-Hydroxymitragynine bind as (partial) agonists to the μ-opioid receptors
Mitragynine and 7-Hydroxymitragynine bind as (partial) antagonists to the κ- and δ-opioid receptors.
Kratom has agonistic affinity for the norepinephrine and serotonin receptor systems.
Kratom contains alkaloids (rhynchophylline and mitraphylline) which function as NMDA receptor antagonists at higher doses. This may be the cause of the mild dissociative effects users report at higher doses (dissociative drugs like PCP and Ketamine are major NMDA-antagonists aswell for example).
They have high binding affinities to the µ- and κ-receptors. The binding affinity to the δ-receptors is high for 7-hydroxymitragynine, but weak for mitragynine
Pharmacokinetics:
Potentiation:
The effects of Kratom are potentiated by:
Antacids: these raise the pH level in the stomach which in turn increases the absorption of Kratom
Turmeric / Curcumin and Black Pepper: these function as a MAOI (MAO-Inhibit0r).
Grapefruit juice: as with a lot of drugs, grapefruit juice can increase the potency of Kratom because it functions as an inhibitor for the enzyme (CYP3A4) that metabolises Kratom
Watercress: in the same way as Grapefruit juice but now due to inhibition of the CYP2E1 enzyme.
Toxicity:
Although a lot less potent, Kratom poseses the same side-effects as regular opioids. These include: nauseau, constipation, decreased libido, apathy and the scariest one: respiratory depression. Unlike other opioids, it's very hard to overdose on Kratom alone due to the high amount one would have to take and the likeliness of becoming nauseus before that dose is reached (most people will start to vomit at doses of 8-9 grams). When combined with other depressants like alcohol, GHB, benzodiazepines or other opioids this risk exponentially increases though. Especially with the more potent concentrations out there, it's not entirely risk free. When combined with stimulants, it may further increase the risk of unwanted effects like abnormal heartbeat, palpitation, agitation and axiety, hypertension and even seizures.
Dependency:
Kratom shares it's dependency and abuse potential with other opioids. However, due to this it is often reported to be very hepful for those suffering from opioid withdrawals!
Edit 2020-02-23:Added the latest version of the TripSit "Drug Combinations" chart under the interactions header. For more information visit:*TripSit.me Wikipage
------
Hi all!
This post is a mega-post / collection of everything related to prescription drugs! The table of contents is as follows:
Table of contents:
Brand names vs Generic names
Drugs Classification
Common indications for drugs
Mechanism of action / Drug Targets
Interaction checker
Short note on drugs and their side effects
NOTE: A link that basically combines all this is http://drugcentral.org/. It allows search queries in all categories named.
1) Brand Names vs Generic Names
For those that don't yet know: a drug always has three names: <chemical name> <generic name> <brand name>
Every drug has at least three names - a chemical name, a generic name, and a brand name. The chemical name describes the atomic or molecular structure of the drug. This name is usually too complex for general use. So commonly, an official body assigns a generic name to a drug. The generic names for drugs of a particular type generally have the same ending. The brand name is selected by manufacturer or distributor of the drug. It is usually shorter and easier to remember than the generic name.
As explained earlier, drugs can also be classified by sharing an indication. This means that multiple types of drugs can be used to treat the same disease. For example: anti-hypertensive drugs include: bèta-blocking drugs, ACE-inhibitors, ARB-receptor blockers, Calcium antagonists, Diuretics and more. Grouping drugs this way is useful for obvious reasons. Also, it enables a doctor to think about combining drugs (for example a bèta-blocker with a Diuretic) if monotherapy isn't efficient enough at treating the disease.
As explained earlier, another way to classify drugs is by grouping them on their mechanism of action / the target the drugs binds to in the body. For example, the anti-acidic drug "Ranitidine" that is used to treat symptoms due too an overproduction of stomach acid targets the Histamine H2 Receptor. Another drug that does this is "Cimetidine". As you may notice, drugs that have the same mechanism of action often share a similarity in their name (suffix). For example: benzodiazepines often end with -zepam (diazepam, temazepam, lorazepam).
Links for section 4: Mechanism of action / Drug targets
As you probably already know, different drugs can interact with eachother. For example, the antidepressant Citalopram (SSRI) should not be taken together with the antidepressant Phenelzine (MAO-inhibitor) because it greatly reduces the chance of serious side effects like Serotonin Syndrome. While most interactions that can cause serious side effects might be well-known, some aren't.
While drugs are, obviously, prescribed to cure symptoms/disease, they almost always come with the inherent risk to cause unwanted symptoms (aka: side-effects). It is up to both the doctor and the patient to make up the balance: does the good outweight the bad? This is an easy choice in some cases, and a near impossible one in others.
Links for section 6: Short note on drugs and their side effects
First time posting on here and hoping I don’t get judged. I have a brother who snorts Percocet and Xanax like a vacuum. I have experience with both drugs but only orally.
What is the difference between the highs when you snort the pills compared to taken orally? Are you supposed to lick the Percocet/ oxycodone before you crush it and snort like OxyContin? I keep hearing on opioid crisis documentaries and shows that the OxyContin has to be licked to break the seal before it is snorted. Also, I have never tried OxyContin.
I have also heard different things in terms that Xanax and Percocet/ oxycodone shouldn’t even be snorted because it’s not worth it and a waste of the pill. I do know that snorting hydrocodone pills is pretty much useless, and better to chew before you swallow?
Any info to clear this up for me would be great appreciated! Thanks again.
N-Acetylcysteine ( NAC) is a substituted amino acid which is primarily used as a medication for treating acetaminophen overdose and to loosen thick mucus in the treatment of cystic fibrosis or chronic obstructive pulmonary disease. Outside of the traditional medical context**, it is gaining in popularity as a nootropic substance that produces mild-to-moderate stimulant effects.**
Pharmacodynamics
In terms of its psychologically beneficial effects, N-acetylcysteine targets glutaminergic and dopaminergic pathways. This could potentially account for its stimulating properties. It is also thought that provision of additional cysteine (an endogenous amino acid) via N-acetylcysteine supplementation reverses function disturbed with usage of drugs in the pathology of addiction.
Mechanism of Action
Administration of acetylcysteine replenishes glutathione stores.
Glutathione, along with oxidized glutathione (GSSG) and S-nitrosoglutathione (GSNO), have been found to bind to the glutamate recognition site of the NMDA and AMPA receptors (via their γ-glutamyl moieties), and may be endogenous neuromodulators. At millimolar concentrations, they may also modulate the redox state of the NMDA receptor complex. In addition, glutathione has been found to bind to and activate ionotropic receptors that are different from any other excitatory amino acid receptor, and which may constitute glutathione receptors, potentially making it a neurotransmitter. As such, since N-acetylcysteine is a prodrug of glutathione, it may modulate all of the aforementioned receptors as well.
Glutathione also modulates the NMDA receptor by acting at the redox site.
Acetylcysteine also possesses some anti-inflammatory effects possibly via inhibiting NF-κB and modulating cytokine synthesis.
Medical Use
Acetaminophen Overdose
Intravenous and oral formulations of acetylcysteine are available for the treatment of paracetamol (acetaminophen) overdose.When paracetamol is taken in large quantities, a minor metabolite called N-acetyl-p-benzoquinone imine (NAPQI) accumulates within the body. It is normally conjugated by glutathione, but when taken in excess, the body's glutathione reserves are not sufficient to deactivate the toxic NAPQI. This metabolite is then free to react with key hepatic enzymes, thereby damaging liver cells.
In the treatment of acetaminophen overdose, acetylcysteine acts to maintain or replenish depleted glutathione reserves in the liver and enhance non-toxic metabolism of acetaminophen. These actions serve to protect liver cells from NAPQI toxicity. It is most effective in preventing or lessening hepatic injury when administered within 8–10 hours after overdose. Research suggests that the rate of liver toxicity is approximately 3% when acetylcysteine is administered within 10 hours of overdose.
Mucus Dissolving
Inhaled acetylcysteine has been used for mucolytic ("mucus-dissolving") therapy in addition to other therapies in respiratory conditions with excessive and/or thick mucus production. It is also used post-operatively, as a diagnostic aid, and in tracheotomy care. It may be considered ineffective in cystic fibrosis.
Psychiatry
Acetylcysteine has been successfully tried as a treatment for a number of psychiatric disorders. A systematic review from 2015, and several earlier medical reviews, indicated that there is favorable evidence for N-acetylcysteine efficacy in the treatment of Alzheimer's disease, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, schizophrenia, specific drug addictions (cocaine), and a certain form of epilepsy (progressive myoclonic) Tentative evidence also supports use in cannabis use disorder.
Nootropic Use
NAC as a precursor of glutathione, is a potent antioxidant, anti-inflammatory and free radical scavenger. Your brainis especially vulnerable to inflammation, free radical and oxidative damage. Affecting cognition, long-term potentiation, memory and mood.
NAC modulates glutamate levels and dopamine release in the brain. Excess glutamate in your brain is toxic to brain cells affecting neuron health, cognition, memory and mood. And NAC protects dopamine receptors. Influencing dopamine levels and function in your brain. Even protecting dopaminergic nerve terminals from chronic methamphetamine use.
NAC reduces irritability, anxiety and depression. NAC increases your body’s antioxidant capacity, and balances excitatory and inhibitory neurotransmitters in your brain. Resulting in less anxiety and depression.
N-acetyl cysteine is LIKELY SAFE for most adults, when used as a prescription medication. It can cause nausea, vomiting, and diarrhea or constipation. Rarely, it can cause rashes, fever, headache, drowsiness, low blood pressure, and liver problems.
Overdose
Dosage ranges more than twenty grams over an extended period may adversely affect heart and lung function.
Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking (PubMed.gov/ NCBI |) http://www.ncbi.nlm.nih.gov/pubmed/16000629
Varga, V.; Jenei, Zs.; Janáky, R.; Saransaari, P.; Oja, S. S. (1997. "Glutathione Is an Endogenous Ligand of Rat Brain N-Methyl-D-Aspartate (NMDA) and 2-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionate (AMPA) Receptors". Neurochemical Research. 22 (9): 1165–1171.)
Oja, S (2000. "Modulation of glutamate receptor functions by glutathione". Neurochemistry International. 37 (2–3): 299–306.)
Berk M, Malhi GS, Gray LJ, Dean OM (March 2013. "The promise of N-acetylcysteine in neuropsychiatry". Trends in Pharmacological Sciences. 34 (3): 167–77.)
Steullet, P.; Neijt, H.C.; Cuénod, M.; Do, K.Q. (2006. "Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia". Neuroscience. 137 (3): 807–819.)
Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuénod M, Buclin T, Do KQ (August 2008. "Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients". Neuropsychopharmacology. 33 (9): 2187–99.)
Dodd S, Dean O, Copolov DL, Malhi GS, Berk M (December 2008. "N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility". Expert Opinion on Biological Therapy. 8 (12): 1955–62.)
Kupchik YM, Moussawi K, Tang XC, Wang X, Kalivas BC, Kolokithas R, Ogburn KB, Kalivas PW (June 2012. "The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine". Biological Psychiatry. 71 (11): 978–86.)
Green JL, Heard KJ, Reynolds KM, Albert D (May 2013. "Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis". The Western Journal of Emergency Medicine. 14 (3): 218–26.)
"Acetadote Package Insert" (PDF. FDA. Archived (PDF) from the original on 25 August 2013.)
Rossi S, editor. Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006.
Dean O, Giorlando F, Berk M (March 2011. "N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action". Journal of Psychiatry & Neuroscience. 36 (2): 78–86.)
Berk M, Malhi GS, Gray LJ, Dean OM (March 2013. "The promise of N-acetylcysteine in neuropsychiatry". Trends in Pharmacological Sciences. 34 (3): 167–77.)
Bavarsad Shahripour R, Harrigan MR, Alexandrov AV (March 2014. "N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities". Brain and Behavior. 4 (2): 108–22.)
Nicotine is a naturally-occurring stimulant substance of the pyrrolidinyl pyridine class. It is the principle alkaloid found in the nightshade family of plants. As the chief ingredient of the tobacco used in cigarettes, cigars, and snuff, it is one of the most widely used substances in the world.
Pharmacodynamics
Nicotine increases flow of adrenaline (epinephrine), a stimulating hormone and neurotransmitter.
It also appears to induce the release of endogenous opioids that activate opioid pathways in the reward system, since naltrexone – an opioid receptor antagonist – blocks nicotine self-administration.
Nicotine is unusual in comparison to most drugs, as its profile changes from stimulant to sedative with increasing dosages, a phenomenon known as "Nesbitt's paradox" after the doctor who first described it in 1969. At very high doses it dampens neuronal activity
Mechanism of Action
Nicotine produces its stimulating effects by agonizing nicotinic acetylcholine receptors, causing the liver to release glucose and the adrenal medulla to release epinephrine.
Once it reaches the brain, nicotine stimulates the release of many neurotransmitters and hormones, including acetylcholine, norepinephrine, epinephrine, arginine vasopressin, serotonin, dopamine, and β-endorphin which are responsible for the majority of its psychoactive effects.
Medical Use
The primary therapeutic use of nicotine is treating nicotine dependence to eliminate smoking and the damage it does to health. Controlled levels of nicotine are given to patients through gums, dermal patches, lozenges, inhalers, electronic/substitute cigarettes or nasal sprays to wean them off their dependence
A 2018 Cochrane Collaboration review found high quality evidence that all current forms of nicotine replacement therapy (gum, patch, lozenges, inhaler, and nasal spray) therapies increase the chances of successfully quitting smoking by 50–60%, regardless of setting.
Recreational Use
Nicotine offers a paradoxical effect where short shallow drags induce stimulation, while long deep drags induce sedation, this is known as Nesbitt’s Paradox.
Short shallow drags cause activation of Alpha-4 beta-2 nicotinic receptors; this in turn causes therelease of dopamine.
Long deep drags appear to induce the release of endogenous opioids that activate opioid pathways in the reward system; this in turn causes sedation and allows nicotine to act as an anxiolytic.
Nootropic Use
A meta-analysis of 41 double-blind, placebo-controlled studies concluded that nicotine or smoking had significant positive effects on aspects of fine motor abilities, alerting and orienting attention, and episodic and working memory.
A 2015 review noted that stimulation of the α4β2 nicotinic receptor is responsible for certain improvements in attentional performance.
By increasing the level of acetylcholine in the brain, nicotine enhances concentration.
Toxicity/Safety
The accepted medical position in 2013 was that nicotine itself poses few health risks, except among certain vulnerable groups.
A 2018 Cochrane review found that, in rare cases, nicotine replacement therapy can cause non-ischemic chest pain. The same review indicated that nicotine replacement therapy does not increase the incidence of serious cardiac adverse events (i.e., myocardial infarction, stroke, and cardiac death) relative to controls.
Overdose
It is unlikely that a person would overdose on nicotine through smoking alone. The median lethal dose of nicotine in humans is unknown.
symptoms of a nicotine overdose typically include nausea, vomiting, diarrhea, hypersalivation, abdominal pain, tachycardia, hypertension, tachypnea, headache, dizziness,auditory or visual disturbances, and perspiration.
Lethal nicotine poisoning rapidly produces seizures, and death – which may occur within minutes – (and) is believed to be due to respiratory paralysis.
Sources
United States National Library of Medicine – Toxicology Data Network. Hazardous Substances Data Bank.
Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T (May 2018). "Nicotine replacement therapy versus control for smoking cessation".
Sarter M (August 2015). "Behavioral-Cognitive Targets for Cholinergic Enhancement"
Heishman SJ, Kleykamp BA, Singleton EG (July 2010). "Meta-analysis of the acute effects of nicotine and smoking on human performance"
Pomerleau OF, Pomerleau CS (1984). Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neuroscience and Biobehavioral Reviews, 8:503-513.
Malenka RC, Nestler EJ, Hyman SE (2009). Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 369, 372–373. ISBN9780071481274.
Welcome to my in-depth guide on ADHD. I have tried to go in-depth but at the same time add bullet points for those that just want the essential information from each subheading. I hope everyone reading this will find it both informative and useful. In the text there are links to more information and resources. At the bottom of the post you will find a resource list for in-depth information. For more readable / user friendly information, I refer to the pages right here:
Note: The Medications listed are click-able and links to in-depth information on that substance!
-- CultriX --
Summary per bullet point:
1: ADHD is a disorder that is characterized by behavioral problems that mainly consist of inattention or hyperactivity and impuslsivity.
2: The underlying causes of ADHD are complex and not fully understood yet. It is known that both structural abnormalities and inbalances in neurotransmissions plays a key part.
3: Pharmacotherapeutic treatment of ADHD relies on trying to restore neurotransmission imbalances. The medications can be roughly divided into Stimulants and Non-Stimulants.
1) What is ADHD
Attention Deficit Hyperactivity Disorder (from now on: ADHD) is considered as a neurodevelopmental disorder that is characterized by severe and age-inappropriate levels of inattention and hyperactivity/impulsitivity. The disorder or label ADHD is usually diagnosed when certain criteria defined in the Diagnostic and Statistical Manual (DSM-V) are met:
Summary 1: ADHD is a disorder that is characterized by behavioral problems that mainly consist of inattention or hyperactivity and impuslsivity.
2)What causes ADHD
The pathophysiological processes that lead to the behavioral changes seen in ADHD are very complex and still not fully understood. We now know that the cause is multifactorial in nature. A brief overview of possible causes includes:
2.1: Differences in brain structure: In children with ADHD there is a general reduction of volume in certain brain structures, with a proportionally greater decrease in the volume in the left-sided prefrontal cortex. Also, the posterior parietal cortex appears to be thinner than in individuals without ADHD. Other brainstructures in the prefrontal-striatal-cerebellar and prefrontal-striatal-thalamic circuits have also been found to show differences between people with/without ADHD. In addition: the subcortical volumes of the accumbens, amygdala, caudate, hippocampus and putamen also show reduction of volume. Finally: inter-hemispheric assymetries have been reported on neuro-imaging studies.
TLDR: There brains of people with ADHD are showing structually differences from people that don't have ADHD
2.2: Differences in Neurotransmitter pathways: Current models involve the mesocorticolimbic dopamine pathway and the locus coeruleus-noradrenergic system. There may be additional abnormalities in the serotoninergic, glutamatergic and cholinergic pathways aswell. While this is very complex, it mainly comes down to this:
There is a imbalance between the neurotransmitters Dopamine, Norepinephrine (and in lesser extent Serotonin)
TLDR: There is an imbalance in neurotransmitters in people with ADHD
Summary 2: The underlying causes of ADHD are complex and not fully understood yet. It is known that both structural abnormalities and inbalances in neurotransmissions plays a key part.
3)Pharmacological Treatment options in ADHD:
The pharmacological treatment of ADHD is (mainly) based on drugs that exert an effect on the neurotransmitters described above in an attempt to restore balance/function. It is possible to make a distinction on the pharmacodynamic effects of the drugs as follows: Stimulants and Non-stimulants. Stimulants increase the activity of monoamergic neurotransmitters in the brain and can be further divided in the way they achieve their effects:
Summary: Methylphenidate (mainly) achieves it's effect by reducing or blocking the re-uptake of neurotransmitters (NDRI)
Pharmacology: Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate also blocks the reuptake of norepinephrine and acts at the brain stem arousal system and the cerebral cortex. It causes increased sympathomimetic activity in the central nervous system. Alteration of serotonergic pathways via changes in dopamine transport may result.
Side-effects include: cardiovascular problems (hypertension, heart palpitations, tachycardia), seizures, insomnia, mood changes, loss of appetite and nausea. RxList-1
Main brands:
Ritalin (instant-release) has a duration of about 3-5 hours
Concerta (slow-release) has a duration of about 8-12 hours
Summary: Amphetamines (mainly) achieve their effects by increasing the release of neurotransmitters (NDRA)
Pharmacology: From its mechanism of action, it has been demonstrated that amphetamine augments the concentration of noradrenaline in the prefrontal cortex and dopamine in the striatum on a dose and time-dependent manner. The indistinct release of neurotransmitters which include adrenaline is known to produce cardiovascular side effects.
Side-effects include: cardiovascular problems (hypertension, heart palpitations, tachycardia), seizures, insomnia, psychosis, mood changes, loss of appetite and nausea. RxList-2
Main brands:
Adderall (instant-release) has a duration of 4 to 6 hours
Summary: Atomoxetine (mainly) achieves its effects by decreasing the re-uptake of norepinephrine.
Pharmacology: The precise mechanism by which atomoxetine produces its therapeutic effects in Attention-Deficit/Hyperactivity Disorder (ADHD) is unknown, but is thought to be related to selective inhibition of the pre-synaptic norepinephrine transporter, as determined through in-vitro studies. Atomoxetine appears to have minimal affinity for other noradrenergic receptors or for other neurotransmitter transporters or receptors.
Summary: Bupropion (mainly) achieves its effects by decreasing the re-uptake of dopamine.
Pharmacology: Bupropion selectively inhibits the neuronal reuptake of dopamine, norepinephrine, and serotonin; actions on dopaminergic systems are more significant than imipramine or amitriptyline whereas the blockade of norepinephrine and serotonin reuptake at the neuronal membrane is weaker for bupropion than for tricyclic antidepressants.
Summary 3: Pharmacotherapeutic treatment of ADHD relies on trying to restore neurotransmission imbalances. The medications can be roughly divided into Stimulants and Non-Stimulants.
IntroductionHello, this is my best attempt at documenting the types, differences, trivia, and information regarding as many opioids as possible. I welcome any and all intelligent contributions. As always, the goal is harm reduction through education. Safe Trips!
Opioids vs. OpiatesOpiates are defined by most dictionaries as "drugs derived from opium" and therefore is only a select group of specific compounds. For something to be an opioid, however, it only needs to bind to opioid receptors in the body and/or brain.
-THE LIST-
Opium - Opium is the basis of the opiate family. It is extracted from the seed pods of certain strains of Poppy plants ( e.g. Papaver somniferum ). Historically, it has been a major crop in Asia for thousands of years. ("3,400 BC" - DEA Museum ) The latex from Opium poppies contain many natural compounds, of these morphine is prevalent. Codeine also naturally occurs in noticeable quantity. A typical P. Somniferum latex contains about 12% morphine, and about 2% codeine, along with many other alkaloids such as thebaine, papaverine, noscapine, and many others in small percentage. ( Wikipedia ) Many wars have been fought over opium, and governments around the world have kept the trade going, In Thailand the government made so much money from opium that when addicts started switching to easily grown Kratom, they demonized the kratom plant. (See the viceland documentary Kratom: The Forbidden Leaf with Hamilton Morris)
Morphine - The main opiate in opium, Morphine is used as the baseline for "analgesic equivalency" of other painkillers. It was named and used in early 1800's Europe - named after Morpheus, the god of sleep because of it's well known sedative effects. It would soon be used for pain. In 1914 it would be restricted by law in America ( Harrison Act ), and in 1970 ( Federal Controlled Substances Act) it was set as a Schedule II drug. Opioid Laws 1800 to present day - NAABT
Codeine - Codeine is converted by the liver in the human body into Morphine. Most of the effects that the user feels come from the metabolized morphine and not the codeine itself. This is an example of a pro-drug Pro-Drugs - Pharmacy Times Because of needing to undergo metabolism, Cytochrome P450 Enzymes are needed, and thus foods and medications that inhibit these need to be avoided. This includes some SSRI's like Paxil/paroxetine prozac/fluoxetine and Buproprion/welbutrin/zyban as well as diphenhydramine/Benadryl and cimetidine/Tagamet. List of inhibitors, WikipediaCodeine is often in combination with Acetominophen - see the Vicodin section for more information.
Laudanum - A tincture of opium base, historically in alcohol, although many different variations existed through the years. It was a common base in many patent medicines from it's original naming by Paracelsus Paracelsus - AAAS.org Possibly as a nod at the opium extraction process (Labdanum - a resinoius extract) Dictionary link Or based on Laudere, the Latin verb for "to praise" Latin Dictionary Link
Vicodin/Hydrocodone/Norco - Vicodin is semi synthetic which is generally prepared in combination with acetaminophen/APAP/Paracetamol. Because of this, the comparatively more toxic Acetaminophen should and can easily be removed with a CWE (Cold Water Extraction). There is already a post in r/FADQ about this procedure.( LINK TO CWE GUIDE ) Vicodin was named after it's relative analgesia - VICodi(e)n(e) with the VI being roman numerals for 6 and the implication being that vicodin is six times more potent than codeine. This seems to be about right based off of conversion charts and calculators. Calculator , Calculator
Percocet/Oxycodone/OxyContin - The big money maker for Purdue Pharma. OxyContin was a coated version of Oxycodone, meaning that it had a "Time release" layer on the outside, the Contin was short for Continual Release, but this was generally defeated by crushing or cutting the pills to remove the outer layer, resulting in plain old oxycodone immediate release. When the patent for OxyContin was about to run out, Purdue somehow managed to get a double-patent with a new formulation. The new OxyContin, commonly referred to as "OP" instead of "OC", are nigh invulnerable and have to be swallowed whole, presumably releasing the oxycodone in a more controlled time-release manner. Percocet is the brand-name for oxycodone & acetaminophen preparations, but aside from the APAP, is the same active ingredient - oxycodone. It is slightly stronger than hydrocodone, for more equivalencies see the Vicodin section.
Dilaudid/Hydromorphone - "A semi-synthetic opioid agonist and a hydrogenated ketone of Morphine first synthesized in Germany in 1921" ( Hydromorphone PDF ) It is significantly stronger than some other opioids, but the ROA (Route of administration) can make a huge difference in the bio availability - this is why 1mg in a hospital IV will feel much stronger than 1 mg in an oral tablet. Regardless of ROA, even people who have a history of opiate use should be careful. Dilaudid - Hydromorphone has a well known effect of incomplete cross-tolerance. This means that what should be an equally analgesic dose could be about twice as strong as it's supposed to be- thus you should always start with far "too little" Dilaudid and work your way up. (About Incomplete Cross Tolerance)
Propoxyphene/Darvon - A painkiller from the 1950s, it was both weak in analgesic potency and fairly toxic, and linked to heart problems. Rarely prescribed past the 1970s in America. In 2010 the FDA called for doctors to stop prescribing it. ( Darvocet/Darvon - FDA website ) Weaker than codeine, but more toxic, this drug didn't last long for good reason.
Oxymorphone/Opana - Similar to how the human body converts codeine into morphine, it also converts oxycodone into oxymorphone. Oxymorphone itself is sold under the brand name Opana ER (Extended Release) ( Opana ER )
Tramadol/Ultram - Tramadol is an opioid in the loosest sense of the word. It's opiate-like effects are attributed to it's mu-receptor binding which is so weak, it's about 6000 times weaker than the binding affinity of morphine. ( Pharmacology of Tramadol - NCBI ) Much stronger than this, however, is Tramadols mechanism as an SNRI ("anti-depressant"). It also has a much higher risk of seizure than other drugs classified as opioids. In the human body, Tramadol is metabolized into a more active metabolite, Desmetramadol ( Wikipedia ), which is still considerably weaker than morphine but is at least 700 times better at binding to opioid receptors than it's pro-drug Tramadol. Different people likely have different amounts of the needed enzymes and thus some people will find next to zero effect from Tramadol.
Naloxone/Narcan - The drug that can save the life of a person who is overdosed on opioids, is itself an opioid. This is entirely necessary, as it's mechanism of action is to replace the other opioids in the patient's receptors. Nalaxone's name is a shortened form of the full name N-Allyl-Oxymorphone. An allyl of oxymorphone with extremely high binding affinity to opioid receptors, that does not cause respiratory depression, euphoria, or any other things generally experienced when under the influence of opioids. This is the "miracle drug" that is saving countless lives. Here is one random website on Narcan, but there are plenty of others: Narcan - DrugAbuse.gov
Suboxone/Subutex/Buprenorphine - Derived from Thebaine (an alkaloid present in Opium, see the Opium section) Buprenorphine is an extremely high binding affninity partial opioid agonist. It is actually as much as 40 times stronger than morphine,as much as 20 times stronger than heroin, but it is used in low dosage for heroin withdrawal and maintenance therapy. ( Buprenorphine treatment - SAMHSA ) It's binding affinity is so high that it actually outbinds narcan nasal spray, required repeated injection and a continuous infusion of naloxone to reverse. ( Naloxone reversal of burenorphine )
Methadone/Dolophine - Methadone is a fully synthetic opioid - meaning it is entirely created in a lab. It was first synthesized in Germany during World War II because they did not have steady access to morphine, the staple painkiller at the time. It has a very long onset and duration, making it a poor choice for recreational abuse. This is why it was used as a treatment and maintenance drug for heroin addiction. The euphoria is considerably less than buprenorphine, heroin, morphine, and pretty much any other opioid. The analgesic effects are quite strong however, making it a useful medicine. It also at high doses is useful for preventing abuse of other drugs thanks to it having a dual mechanism of a "cieling" dose at which no more effects are likely to be achieved and a "blocking" ability by occupying the receptors that more euphoric opioids would need to latch onto. Methadone was originally called "Dolophine" from the latin "Dolor" meaning pain.
Heroin/Diacetylmorphine - Also known as diamorphine, it is a highly addictive morphine derivative. It is active itself, and metabolizes into both morphine and the novel 6-monoacetylmorphine Both of these metabolites are active as well. This combination of highly active compounds are what causes the addictive rush and euphoria related to heroin. It can be consumed through smoking, eating, snorting or injecting, and comes in several different processed forms, ranging from black tar all the way to white powder. Heroin is actually the brand-name that was chosen by Bayer to sell it under.
Fentanyl - A fully synthetic opioid that is "80-100 times stronger than morphine" DEA Fentanyl Fact Sheet It is often cut into heroin or pressed into fake pills and misrepresented as pills like oxycodone. It is considerably stronger than other opioids, and despite having a short half-life it has a strong respiratory depression. A large portion of opioid deaths happen because of someone accidentally buying fentanyl that was misrepresented as a weaker opioid.
Carfentanyl - An opioid roughly 100 times stronger than fentanyl which is already 100 times stronger than morphine. This is not actually for pain management at all, it's used to sedate extremely large animals hence the nickname "elephant tranquilizer" For reference here's another set of equivalent strengths: Opioid Strength Comparisons (including Carfentanyl)
Kratom/Mitragynine - This compound comes from a tree native to South-East Asia. For more information see: Kratom Info on r/FADQ
Loperamide/Immodium AD - an OTC opioid that is sold as an anti-diarrhea medicine. It works by binding to the opioid receptors in the intestinal tract (slowing down bowel movement) while not being able to cross the Blood Brain Barrier (BBB) and thus not giving any of the euphoric effects caused by the brain's opioid receptors being occupied. However, there are research papers that say that with the correct carrier loperamide can be forced to cross the BBB ( Nanoparticles ) There is also the possibility that taking 5-10 times a normal dose could cause some of the loperamide to cross the BBB but at this dosage negative side effects are to be expected. ( Loperamide Abuse )
Conclusion - I hope that this information proves useful to someone. As always harm reduction is the goal and doing your own diligent research is the best way towards that end. If there is anything I forgot about and left out, please let me know so I can add it to the list, Safe Trips!-Sknarp
Amphetamine is a central nervous systemstimulant that is used in the treatment of attention deficit hyperactivity disorder , narcolepsy, and obesity. Historically, it has been used to treat nasal congestion and depression. Amphetamine is also used as an athletic performance enhancer and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant. It is a prescription drug in many countries, and unauthorized possession and distribution of amphetamine are often tightly controlled due to the significant health risks associated with recreational use.
Pharmacodynamics
Amphetamine has been identified as a potent full agonist of trace amine-associated receptor 1 (TAAR1), a Gs-coupled and Gq-coupled G protein-coupled receptor (GPCR) discovered in 2001, which is important for regulation of brain monoamines. Activation of TAAR1 increases cAMP production via adenylyl cyclase activation and inhibits monoamine transporter function. Monoamine autoreceptors (e.g., D2 short, presynaptic α2, and presynaptic 5-HT1A) have the opposite effect of TAAR1, and together these receptors provide a regulatory system for monoamines and interacts with vesicular monoamine transporter 2 (VMAT2). Combined action on TAAR1 and VMAT2 results in increased concentrations of dopamine and norepinephrine in the synapses, which stimulates neuronal activity.
Mechanism of Action
Amphetamine induces the collapse of the vesicular pH gradient, which results in the release of dopamine molecules from synaptic vesicles into the cytosol via dopamine efflux through VMAT2. Subsequently, the cytosolic dopamine molecules are released from the presynaptic neuron into the synaptic cleft via reverse transport at DAT
Similar to dopamine, amphetamine dose-dependently increases the level of synaptic norepinephrine, the direct precursor of epinephrine. Based upon neuronal TAAR1 mRNA expression, amphetamine is thought to affect norepinephrine analogously to dopamine. In other words, amphetamine induces TAAR1-mediated efflux and non-competitive reuptake inhibition at phosphorylated NET, competitive NET reuptake inhibition, and norepinephrine release from VMAT2.
Medical Use
Amphetamine is used to treat attention deficit hyperactivity disorder (ADHD), narcolepsy (a sleep disorder), and obesity, and is sometimes prescribed off-label for its past medical indications, particularly for depression and chronic pain. Long-term amphetamine exposure at sufficiently high doses in some animal species is known to produce abnormal dopamine system development or nerve damage, but, in humans with ADHD, pharmaceutical amphetamines appear to improve brain development and nerve growth. Reviews of magnetic resonance imaging (MRI) studies suggest that long-term treatment with amphetamine decreases abnormalities in brain structure and function found in subjects with ADHD, and improves function in several parts of the brain, such as the right caudate nucleus of the basal ganglia.
Recreational Use
amphetamine use can lead to motivation enhancement, stamina enhancement, appetite suppression, increased libido, and euphoria. At heavier doses, it can induce states of anxiety & paranoia, delusions, thought disorganization and psychosis.
Side Note: comparatively to drugs like Methamphetamine, Amphetamine is generally more tame in terms of compulsiveness. In my personal opinion i find this is due to the lack of more instantly gratifying route of administrations.
Enhancement Use
In 2015, a systematic review and a meta-analysis of high quality clinical trials found that, when used at low (therapeutic) doses, amphetamine produces modest yet unambiguous improvements in cognition, including working memory, long-term episodic memory, inhibitory control, and some aspects of attention, in normal healthy adults; these cognition-enhancing effects of amphetamine are known to be partially mediated through the indirect activation of both dopamine receptor D1 and adrenoceptor α2 in the prefrontal cortex.
A systematic review from 2014 found that low doses of amphetamine also improve memory consolidation, in turn leading to improved recall of information. Therapeutic doses of amphetamine also enhance cortical network efficiency, an effect which mediates improvements in working memory in all individuals. However, high amphetamine doses that are above the therapeutic range can interfere with working memory and other aspects of cognitive control.
An amphetamine overdose can lead to many different symptoms, but is rarely fatal with appropriate care. The severity of overdose symptoms increases with dosage and decreases with drug tolerance to amphetamine. Tolerant individuals have been known to take as much as 5 grams of amphetamine in a day, which is roughly 100 times the maximum daily therapeutic dose.Symptoms of a moderate and extremely large overdose are listed below; fatal amphetamine poisoning usually also involves convulsions and coma. In 2013, overdose on amphetamine, methamphetamine, and other compounds implicated in an "amphetamine use disorder" resulted in an estimated 3,788 deaths worldwide (3,425–4,145 deaths, 95% confidence).
Sources
Heal DJ, Smith SL, Gosden J, Nutt DJ (June 2013. "Amphetamine, past and present – a pharmacological and clinical perspective". J. Psychopharmacol. 27 (6): 479–496. doi:10.1177/0269881113482532. PMC 3666194. PMID 23539642)
Yoshida T (1997. "Chapter 1: Use and Misuse of Amphetamines: An International Overview". In Klee H (ed.). Amphetamine Misuse: International Perspectives on Current Trends. Amsterdam, Netherlands: Harwood Academic Publishers. p. 2.)
Malenka RC, Nestler EJ, Hyman SE (2009. "Chapter 13: Higher Cognitive Function and Behavioral Control". In Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York, USA: McGraw-Hill Medical. pp. 318, 321.)
Liddle DG, Connor DJ (June 2013. "Nutritional supplements and ergogenic AIDS". Prim. Care. 40 (2): 487–505.)
United States Food and Drug Administration. Shire US Inc. December 2013.
"Adderall XR Prescribing Information" (PDF. United States Food and Drug Administration. Shire US Inc. December 2013. p. 11.)
"Convention on psychotropic substances". United Nations Treaty Collection. United Nations. Archived
Rasmussen N (July 2006. "Making the first anti-depressant: amphetamine in American medicine, 1929–1950". J. Hist. Med. Allied Sci. 61 (3): 288–323.)
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S (January 2008. "Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature". J. Am. Acad. Child Adolesc. Psychiatry. 47 (1): 21–31.)
Medical Subject Headings. United States National Library of Medicine.
"Guidelines on the Use of International Nonproprietary Names (INNS for Pharmaceutical Substances". World Health Organization. 1997.)
Miller GM (January 2011. "The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity". J. Neurochem. 116 (2): 164–176.)
Ilieva IP, Hook CJ, Farah MJ (June 2015. "Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis". J. Cogn. Neurosci. 27 (6): 1–21. doi:10.1162/jocn_a_00776. PMID 25591060.)
Spencer RC, Devilbiss DM, Berridge CW (June 2015. "The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex". Biol. Psychiatry. 77 (11): 940–950. doi:10.1016/j.biopsych.2014.09.013. PMC 4377121. PMID 25499957.)
Bidwell LC, McClernon FJ, Kollins SH (August 2011. "Cognitive enhancers for the treatment of ADHD". Pharmacol. Biochem. Behav. 99 (2): 262–274.)
Eiden LE, Weihe E (January 2011. "VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse". Ann. N. Y. Acad. Sci. 1216: 86–98.)
This is a HUGE step in America towards legalizing shrooms, and towards other drugs of the like. The thoughts and culture around certain drugs that have the potential to be helpful medicinally is changing in our country. I’m so glad to be alive to witness this history being made!
Taken from The NY Times, “But the measure made the possession, use or cultivation of the mushrooms by people aged 21 or older the lowest-priority crime for law enforcement in the city of Denver and Denver County. Arrests and prosecutions, already fairly rare, would all but disappear.
Results posted by the city as a “final unofficial” tally late on Wednesday showed the “Yes” vote won by less than 2,000 ballots. The “No” vote had led throughout the day, until the last updated count by elections officials. Alton P. Dillard, the elections spokesman, said the passage appeared safe, but the final results would not be certified until May 16.”
Medication with potential effects in restoring dopaminergic functioning.
Ibudilast may dampen cravings and improve cognitive functioning and a cure
for methamphetamine addiction.
Ibudilast may prevent the activation of certain cells in the central nervous
system, called glial cells, which have been linked to drug dependence.
Treatment prevented compulsive- like contextual-driven METH seeking, and these
behavioral effects correlated with reduced or abolished neurogenesis in the DG
and reduced activation of plasticity-related protein calcium calmodulin kinase
(CaMKII) in the DG.
This medication has been shown to suppress both amphetamine induced release and
conditioned place preference. In healthy human volunteers, we have shown that
Isradipine reduces some of the positive subjective effects of methamphetamine
associated with its abuse liability. It has been hypothesized that the
mechanisms of dihydropyridine (L-type calcium channel antagonists blockers)
contribute to their antireinforcing effects on amphetamines, such as interference
with post-synaptic gene and hormone expression and impulse propagation.
The dihydropyridine class calcium channel antagonists reduce the rewarding effects
of amphetamines, and would provide additional support for the DA theory of brain
reward.
Lobeline, a piperidine alkaloid from Lobelia, stimulates dopamine released to
a moderate extent when administered alone, but reduces the dopamine release
caused by methamphetamine.
Inhibits the catabolism of GABA, acting as a sedative. It has previously been
found effective for methamphetamine dependence. Blocking effect caused by its
actions upon reward mechanism.
Sidenote: Seems to be available from many different online vendors rather than by prescription but due to the nature of Reddit i can not provide any links to buying this chemical.
Adult neurogenesis in the dentate gyrus modulated neurogenesis, neuronal
activation and structural plasticity of GCNs, and expression of synaptic
proteins associated with learning and memory in the DG. These findings
identify a subset of newly born GCNs within the DG that could directly
contribute to drug-seeking behavior.
NMII inhibitor in the middle of a drug development program supported
by the NIH’s Blueprint Neurotherapeutics Network to develop a clinically
safe NMII inhibitor. The goal is to enter a Phase 1a safety trial in 2020.
"mTOR-induced autophagy inhibition exacerbates the ultrastructural effects
of METH, while rapamycin administration reverts both behavioral and
morphological alterations induced by METH."
Acts as a partial agonist at the D2/3/4 receptors, which probably explains
its effectiveness in treating meth dependence. An inverse agonist doesn't
really fulfill the role of an agonist because it blocks both the effects of
agonists, and also eliminates intrinsic receptor activity.
A mixed agonist. Acts on both serotonin and dopamine, which are thought to
be beneficial for the treatment of stimulant addiction. β-phenylethylamine
is known to possess agonistic properties towards both of these
neurotransmitters.
Substitute Desoxyn for street methamphetamine prescribed at a therapeutic level
to be clinically effective is in the 20mg-70mg range, which is much smaller than
recreational doses.
While this drug has not been shown to affect meth use, it has been shown to reduce
meth cravings. Dextroamphetamine is itself an addictive stimulant, but is available
as a prescription tablet—potentially facilitating closer medical vigilance and safer
dosing while mitigating cravings.
The Emsam (Selegiline) transdermal patch actually lowers the amphetamine byproducts
delivered into the system that would normally be produced by the oral tablet/capsule
despite the patch delivering a much higher dose than the oral dosage form.
A second-generation propargylamine that irreversibly and selectively inhibits
monoamine oxidase type B (MAO-B). It is useful in dealing with non-motor symptoms
like fatigue,and it also offers neuroprotection.
"Methamphetamine leads to the loss of SNc dopaminergic neurons not by increasing
cytosolic quinones but by increasing mitochondrial oxidant stress through a
MAO-dependent mechanism. Moreover, the toxicity of methamphetamine could be
dramatically attenuated with an FDA approved drug, rasagiline."
MH6 vaccine was clearly able to block some of methamphetamine’s central nervous
system effects, which keeps the antibodies at high levels to prevent meth from
rapidly entering the brain.
Sidenote: Seems to be available from many different online vendors rather than by prescription but due to the nature of Reddit i can not provide any links to buying this chemical.
This epigenetic approach is also used to treat underlying cellular mechanisms,as well
as target molecular mechanisms. Shown to reverse changes in DNA methylation and HPA
responsiveness to restraint and behavioral responses to stress and substance abuse.
u/jasijo is responsible for all the research done in this post so id like to thank her for that!
Methamphetamine is a potent central nervous system stimulant that is mainly used as a recreational drug and less commonly as a second-line treatment for attention deficit hyperactivity disorder and obesity. It is rarely prescribed over concerns involving human neurotoxicity and potential for recreational use as an aphrodisiac and euphoriant, among other concerns, as well as the availability of safer substitute drugs with comparable treatment efficacy.
Pharmacodynamics
Methamphetamine has been identified as a potent full agonist of trace amine-associated receptor 1 (TAAR1), a G protein-coupled receptor (GPCR) that regulates brain catecholamine systems. Activation of TAAR1 increases cyclic adenosine monophosphate (cAMP) productionand either completely inhibits or reverses the transport direction of the dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT).
Methamphetamine is also an agonist of the alpha-2 adrenergic receptors and sigma receptors with a greater affinity for σ1 than σ2, and inhibits monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Mechanism of Action
When methamphetamine binds to TAAR1, it triggers transporter phosphorylationresulting in the internalization or reverse function of monoamine transporters. Methamphetamine isknown to increase intracellular calcium, in turn producing dopamine efflux. To a lesser extent the reuptake of norepinephrine and serotonin inhibits the activity of their transporters, allowing them to accumulate in the synaptic cleft between neurons in various brain regions.
Sigma receptor activation by methamphetamine facilitates its central nervous system stimulant effects and promotes neurotoxicity within the brain. Methamphetamine is known to inhibit the CYP2D6 liver enzyme as well.
Medical Use
In the United States, dextromethamphetamine hydrochloride, under the trade name Desoxyn, has been approved by the FDA for treating ADHD and obesity in both adults and children; however, the FDA also indicates that the limited therapeutic usefulness of methamphetamine should be weighed against the inherent risks associated with its use. Methamphetamine is sometimes prescribed off label for narcolepsy and idiopathic hypersomnia. In the United States, methamphetamine's levorotary form is available in some over-the-counter (OTC) nasal decongestant products.
Recreational Use
Methamphetamine is a potentstimulant, its effects can last 6-12 hours. The durationof methamphetamine's effects depends on the amount taken and the route of administration**(ROA)**.
Methamphetamine use can lead to motivation enhancement, stamina enhancement, appetite suppression, increased libido, and euphoria. At heavier doses, it can induce states of anxiety & paranoia, delusions, thought disorganization and psychosis. It is associated with compulsive redosing, especially when it is vaporized ("smoked") or injected, due to the initial overwhelming euphoric rush it produces.
Unlike amphetamine, methamphetamine is directly neurotoxic to dopamine neurons. Moreover, methamphetamine abuse is associated with an increased risk of Parkinson's disease due to excessive pre-synaptic dopamine autoxidation, a mechanism of neurotoxicity. Similar to the neurotoxic effects on the dopamine system, methamphetamine can also result in neurotoxicity to serotonin neurons. It has been demonstrated that a high core temperature is correlated with an increase in the neurotoxic effects of methamphetamine. As a result of methamphetamine-induced neurotoxicity to dopamine neurons, chronic use may also lead to post acute withdrawals which persist beyond the withdrawal period for months, and even up to a year.
A methamphetamine overdose may result in a wide range of symptoms and is potentially fatal at heavy doses. A moderate overdose of methamphetamine may induce symptoms such as abnormal heart rhythm, confusion, dysuria, high or low blood pressure, hyperthermia, hyperreflexia, myalgia, severe agitation, tachypnea, tremor, urinary hesitancy, and urinary retention. An extremely large overdose may produce symptoms such as adrenergic storm, methamphetamine psychosis, anuria, cardiogenic shock, cerebral hemorrhage, circulatory collapse, hyperpyrexia, pulmonary hypertension, renal failure, rhabdomyolysis, serotonin syndrome, and a form of stereotypy ("tweaking"). A methamphetamine overdose will likely also result in mild brain damage due to dopaminergic and serotonergic neurotoxicity. Death from fatal methamphetamine poisoning is typically preceded by convulsions and coma.
Sources
Miller GM (January 2011. "The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity". J. Neurochem. 116 (2): 164–176. doi:10.1111/j.1471-4159.2010.07109.x. PMC 3005101. PMID 21073468.)
Methamphetamine. DrugBank. University of Alberta. 8 February 2013.
Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (July 2001. "Trace amines: identification of a family of mammalian G protein-coupled receptors". Proc. Natl. Acad. Sci. U.S.A. 98 (16): 8966–8971. Bibcode:2001PNAS...98.8966B. doi:10.1073/pnas.151105198. PMC 55357. PMID 11459929.)
Xie Z, Miller GM (July 2009. "A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain". J. Pharmacol. Exp. Ther. 330 (1): 316–325. doi:10.1124/jpet.109.153775. PMC 2700171. PMID 19364908.)
Maguire JJ, Davenport AP (2 December 2014. "TA1 receptor". IUPHAR database. International Union of Basic and Clinical Pharmacology.)
Underhill SM, Wheeler DS, Li M, Watts SD, Ingram SL, Amara SG (July 2014.)
Ledonne A, Berretta N, Davoli A, Rizzo GR, Bernardi G, Mercuri NB (July 2011.mct (28 January 2012). "TAAR1". GenAtlas. University of Paris. Retrieved 29 May 2014.)
Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC (May 2011Canadian Institutes of Health Research. How Drugs Affect Neurotransmitters. Web 2007. Available from: URL:) http://thebrain.mcgill.ca/flash/i/i_03/i_03_m/i_03_m_par/i_03_m_par_cocaine.html#drogues
Yu S, Zhu L, Shen Q, Bai X, Di X (March 2015. "Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology". Behav. Neurol. 2015: 1–11. doi:10.1155/2015/103969. PMC 4377385. PMID 25861156.)
Mitler MM, Hajdukovic R, Erman MK (1993. "Treatment of narcolepsy with methamphetamine". Sleep. 16 (4): 306–317. PMC 2267865. PMID 8341891.)
Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, Boehlecke B, Chesson AL Jr, Friedman L, Maganti R, Owens J, Pancer J, Zak R, Standards of Practice Committee of the American Academy of Sleep Medicine (2007. "Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin". Sleep. 30 (12): 1705–11. PMC 2276123. PMID 18246980.)
Westfall DP, Westfall TC (2010. "Miscellaneous Sympathomimetic Agonists." In Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman's Pharmacological Basis of Therapeutics (12th ed.). New York: McGraw-Hill. ISBN 978-0-07-162442-8.)
Malenka RC, Nestler EJ, Hyman SE (2009. "15". In Sydor A, Brown RY. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. p. 370. ISBN 978-0-07-148127-4. "Unlike cocaine and amphetamine, methamphetamine is directly toxic to midbrain dopamine neurons.")
Hofmann FG (1983. A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects (2nd ed.). New York: Oxford University Press. p. 329. ISBN 9780195030570.)
I’m actually an NP, but didn’t write those posts from a medical perspective - Just the scared shitless patient one. But I’m happy to talk shop now and tell you a little about my spontaneous intracerebral hemmorhage.. if you’re interested.